Skip to main content
search

Late Clinical

Sign up

Latest resources

Featured resource

Upcoming late clinical webinars

Webinar

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

US (ET): Thursday, November 6, 11:00am – 11:30am EMEA (GMT): Thursday, November 13, 10:00am – 10:30am APAC (JST): Thursday, November
Webinar

Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights

December 2, 2025 – 11am EST - 12pm EST
Webinar

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

December 16, 2025 – 11:00am - 12:00pm ET

Latest late clinical blogs

Meet our experts at the following events

Conference

PHUSE EU Connect

November 16 - 19, 2025 – Hamburg, Germany
Conference

JSCPT 2025 – The 46th Annual Scientific Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics

We’re excited to participate in JSCPT 2025 in Tokyo, The 46th Annual Scientific Meeting of The Japanese Society of Clinical
Conference

SOT Annual Meeting and ToxExpo 2026

March 22 - 25, 2026 – San Diego, CA – Booth 2024

All late clinical resources

Development of a Predictive Pharmacokinetic Model for a Novel Cyclooxygenase-2 Inhibitor

Central Nervous System (CNS), Model Informed Drug Development, Modeling and Simulation - PK/PD, pre-update, Therapeutic Specialties, Publication

Enriched Analgesic Efficacy Studies: An Assessment by Clinical Trial Simulation

Central Nervous System (CNS), Clinical Trials, Model Informed Drug Development, Modeling and Simulation - PK/PD, pre-update, Therapeutic Specialties, Publication

Model-based Development of Gemcabene, a New Lipid-altering Agent

Cardiovascular, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, pre-update, Therapeutic Specialties, Publication

Therapeutic Benefit of Eletriptan Compared to Sumatriptan for the Acute Relief of Migraine Pain—Results of a Model-based Meta-analysis that Accounts for Encapsulation

Central Nervous System (CNS), Certara Services, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation - PK/PD, pre-update, Therapeutic Specialties, Publication

Does Neuromuscular Electrical Stimulation Strengthen the Quadriceps Femoris? A Systematic Review of Randomized Controlled Trials

Model Informed Drug Development, pre-update, Publication

Population Pharmacokinetics of Olmesartan Following Oral Administration of Its Prodrug, Olmesartan Medoxomil: In Healthy Volunteers and Hypertensive Patients

Cardiovascular, Model Informed Drug Development, Modeling and Simulation - PK/PD, pre-update, Therapeutic Specialties, Publication

The Use of Clinical Trial Simulation to Support Dose Selection: Application to Development of a New Treatment for Chronic Neuropathic Pain

Central Nervous System (CNS), Clinical Trials, Model Informed Drug Development, Modeling and Simulation - PK/PD, pre-update, Therapeutic Specialties, Publication

Pharmacokinetics of Melagatran and the Effect on Ex Vivo Coagulation Time in Orthopedic Surgery Patients Receiving Subcutaneous Melagatran and Oral Ximelagatran: A Population Model Analysis

Cardiovascular, Model Informed Drug Development, Modeling and Simulation - PK/PD, Oncology/Hematology, pre-update, Therapeutic Specialties, Publication

Combining Drug-disease and Economic Modeling to Inform Drug Development Decisions

Infectious Disease, Modeling and Simulation - PK/PD, pre-update, Publication

A Population Pharmacokinetic/Pharmacodynamic Analysis of Repeated Measures Time-to-event Pharmacodynamic Responses: The Antiemetic Effect of Ondansetron

Model Informed Drug Development, Modeling and Simulation - PK/PD, pre-update, Publication
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.